[Morphological study of a prolactin-secreting pituitary adenoma after therapy with 2-bromo-alpha-erogocryptine (CB154) (author's transl)].
After treatment with CB 154 of a prolactin-secreting pituitary adenoma a morphological study reveales that many cells present a positive immunofluorescent reaction with anti-ovine prolactine antibody. At the ultra structural level, many granulations and vacuolated dense bodies can be observed.
D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism* / Q000648:ultrastructure; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000648:ultrastructure; D011388:Prolactin / Q000378:metabolism*
D004873:Ergolines; D001971:Bromocriptine; D011388:Prolactin
Etude morphologique d'un adénome à prolactine après traitement par la 2-bromo-alpha-ergocryptine (cb 154)